WarrenIsakowMD
Pulmonology • Saint Louis, MOCritical Care Medicine, Interventional Pulmonology, Pleural Disease
Assistant Professor, Internal Medicine, Washington University in St. Louis School of Medicine
Dr. Isakow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
Ste 8B
Saint Louis, MO 63110Phone+1 314-454-8917Fax+1 314-454-2200
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2006- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2000 - 2003
University of the WitwatersrandClass of 1998
Certifications & Licensure
AZ State Medical License 2018 - 2027
WV State Medical License 2019 - 2026
AR State Medical License 2024 - 2026
VA State Medical License 2018 - 2026
PA State Medical License 2018 - 2026
OH State Medical License 2018 - 2026
MO State Medical License 2003 - 2026
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
- Join now to see all
Clinical Trials
- Hemodynamic Optimization By Non-Invasive Determination Of Cardiac Output In Critically Ill Patients Start of enrollment: 2010 Jan 01
Publications & Presentations
PubMed
- 8 citationsRisk Factors for Loss of Lung Sliding in a Medical Intensive Care Population With Acute Respiratory Failure.Christopher Mallow, Warren Isakow
Journal of Bronchology & Interventional Pulmonology. 2019-04-01 - 11 citationsDiscrepancies in measuring bladder volumes with bedside ultrasound and bladder scanning in the intensive care unit: A pilot study.Donna Prentice, Carrie Sona, Brian Wessman, Enyo Ablordeppey, Warren Isakow
Journal of the Intensive Care Society. 2018-05-01 - 8 citationsThe peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by ...Delphine L. Chen, Howard J. Huang, Derek E. Byers, Adrian Shifren, Bryan G Belikoff
Plos One. 2018-02-07
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
